Aug 2026· Acta Neurologica Belgica· 0 citations· 23 references
Medicine
TL;DR
Brain perfusion analysis revealed that reduced blood flow to the precentral gyrus at baseline was associated with the manifestation of pyramidal signs at the endpoint, and greater increases in the ICARS scores over time and an earlier onset of wheelchair dependence.
Although AT subtypes differ substantially in childhood and adolescence, neurological decline converges to a similar pace in adulthood, irrespective of subtype or genotype, which inform counselling, prognostication, and the design of interventional trials, including mutation-specific therapies.
A. Hensiek, L. Bottolo, M. Tiet et al.· Brain : a journal of neurolo...· 0 citations
Background: Spinocerebellar ataxias (SCAs) are progressive neurodegenerative disorders increasingly recognized to have substantial non-motor manifestations. Data regarding these symptoms in the Kashmiri population remain limited.
Objective: To assess the prevalence and pattern of non-motor symptoms among genetically co...
B. Sanaie, S. Tak, Tanveer Hassan et al.· National journal of medical...· 0 citations
Neuronopathic Gaucher disease (GD types II and III) represents rare and severe phenotypes of glucocerebrosidase deficiency, characterized by neurological involvement and variable systemic manifestations. Data on clinical presentation and genotype–phenotype patterns in Eastern European populations remain limited. We con...
N. Samonenko, N. Olkhovych, O. Okhotnikova et al.· Orphanet Journal of Rare Dis...· 0 citations
Background: Mucopolysaccharidosis type II (MPS II) is a progressive, rare, X-linked inherited disease with multi-organ involvement and a restricted life expectancy. The disease has two main forms: neuronopathic (severe) and non-neuronopathic (attenuated). Aim: To compare the two main forms of MPS II to identify signs f...
Nataliya V. Buchinskaia, E. Zakharova, Anastasia O. Vechkasova et al.· Medical Science· 0 citations
The results highlight the need for a unified diagnostic framework for ATP1A3-related disorders and demonstrate the feasibility and scientific value of coordinated rare disease research in resource-limited settings.
Victor Rebelo Procaci, Raphael Pinheiro Camurugy da Hora, Anna Maria Gomes et al.· Neurology: Genetics· 0 citations